Literature DB >> 6449520

Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis.

S P James, C O Elson, J G Waggoner, E A Jones, W Strober.   

Abstract

In this study we show that patients with primary biliary cirrhosis (PCB) have a marked deficiency in the ability to generate an autologous mixed lymphocyte reaction (AMLR) but have a normal ability to generate an allogeneic mixed lymphocyte reaction (MLR). This deficiency is not due to differences in the time-course of the proliferative response or to an altered response to variable numbers of stimulator cells. The deficiency was consistently found irrespective of the methods used to isolate autologous stimulator cells. Both responder cells and stimulator cells obtained from patients with PBC were similar to normal cells in their ability to generate an MLR in allogeneic normal human serum. In addition, serum from patients with PBC inhibited the ability of normal lymphocytes to generate both the AMLR and MLR to a similar degree, suggesting that the defect of the AMLR in PBC is not due to a serum factor. It has been shown that the responder cell population in the AMLR contains a subpopulation of cells that mediate suppression. Therefore, it is possible that the deficiency of the AMLR may be related to previously described abnormalities of suppressor function in patients with PBC.

Entities:  

Mesh:

Year:  1980        PMID: 6449520      PMCID: PMC371615          DOI: 10.1172/JCI109982

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems.

Authors:  J B Smith
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

3.  Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction.

Authors:  N L Gerber; J A Hardin; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

4.  Circulating immune complexes and complement activation in primary biliary cirrhosis.

Authors:  J R Wands; J L Dienstag; A K Bhan; E R Feller; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

5.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction.

Authors:  M E Weksler; R Kozak
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

8.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

Authors:  R A Vande Stouwe; H G Kunkel; J P Halper; M E Weksler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  23 in total

1.  AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.

Authors:  M Vanoli; R Scorza Smeraldi; G Fabio; P Bonara; M G Sabbadini; C Zanussi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 2.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).

Authors:  K Yamamoto; S M Akbar; T Masumoto; M Onji
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 4.  Primary biliary cirrhosis. Is (and how much of) the pathology preventible?

Authors:  Y Bar-Dayan; M E Gershwin; Y Levi; H Amital; Y Shoenfeld
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

Authors:  R Saeki; H Ogino; S Kaneko; M Unoura; K Kobayashi
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

6.  Immunoglobulin secretion in human disease states.

Authors:  M G Beale; R P MacDermott
Journal:  Surv Immunol Res       Date:  1983

7.  Frequency in human peripheral blood of T cells which respond to self, modified self and alloantigens.

Authors:  J B Smith
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

8.  Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

Authors:  A Laffón; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  Increased peripheral blood Ia positive T cells and their effect on autologous mixed lymphocyte reaction in chronic active liver disease.

Authors:  K Fukui; S Kakumu; H Murakami; J Kuriki; K Yoshioka; N Sakamoto
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

10.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.